We're excited to announce that Professor David Dexter has joined us as our new Deputy Director of Research.

Parkinson's UK and the University of Sheffield have launched a new £1million virtual biotech company, Keapstone Therapeutics, to combine world-leading research from the University with funding and expertise from the charity to develop new treatments.

US researchers have announced the launch of a Phase II clinical trial of the cancer drug nilotinib in people with Parkinson’s.

Results from a clinical trial suggest an inhalable form of levodopa could help people with Parkinson's who experience 'off periods'.

Researchers have discovered a potential way to tell the difference between people with Parkinson's and those with parkinsonisms using a simple blood test.

Researchers in Oxford have developed a unique way to identify existing drugs that could potentially be repurposed for treating Parkinson’s.

A natural molecule called squalamine may hold the key to preventing Lewy bodies forming in Parkinson's, according to groundbreaking new research.

Gut microbes could play a critical role in the development of Parkinson's, according to groundbreaking new research published on Thursday 1 December.

A round-up of 2016's exciting developments in Parkinson's research - and how you can get involved in 2017. 

A research team at Imperial College are testing the use of high-intensity, focused ultrasound waves for the first time in the UK to treat tremor.